Clin2
NCT07529561Possibly a fitNot yet recruiting

CL25216 for menstrual pain and hormone balance

Primary DysmenorrheaMenstural Cramps

Part of Pain, Women’s health & pregnancy clinical trials.

This study tests whether a new medication called CL25216 can reduce severe menstrual cramps and help balance hormones in women. If you experience moderate to severe period pain, this trial might help you find relief.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
25 years to 40 years
Study type
Interventional

Who can take part

  • You are a woman aged 25–40 with a BMI (body weight measure) between 25–29
  • You have had moderate to severe menstrual cramps (Grade 2 pain) for at least 3 cycles, with pain rating of 4 or higher on a 10-point scale
  • Your periods come regularly every 21–35 days and last 3–7 days
  • You have no gynecological conditions (like endometriosis), no pelvic surgery history, and normal pelvic and breast imaging
  • You agree not to use pain relievers (like ibuprofen) for 24 hours before screening and throughout the study
  • You use non-hormonal birth control (not pills or IUDs) and commit to all study visits and procedures

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05640232Recruiting· Phase 3
Test medicine CDE100 for severe menstrual cramp pain

This Phase 3 study tests whether CDE100 can reduce menstrual cramp pain in people with primary dysmenorrhea (cramps that are not caused by another medical condition). It also checks how safe the treatment is and how it’s tolerated over time.

Hortolândia, São Paulo
NCT06268054Not yet recruiting· Phase 3
Testing a new medicine for menstrual cramps

This study tests a new medicine (DEH113) to see how well it reduces menstrual cramp pain in women with primary dysmenorrhea. If you have moderate to severe cramps during your period and haven't had problems with common pain relievers like ibuprofen, this trial might help find a new option for you.

NCT06555549Not yet recruiting
Testing DEH113 for Period Cramps

This study tests an experimental medication called DEH113 to see if it safely and effectively reduces menstrual cramps in women with primary dysmenorrhea (period pain without another underlying condition). If you have moderate or severe cramps and have not found enough relief from other treatments, this trial may be an option.

NCT07376759Not yet recruiting
Pain relief study for period cramps

This study tests a comfort-based method to help women with period pain. It's for single women with regular cycles who have moderate to severe cramps.

NCT07176780Not yet recruiting
Wearable sleeve for period pain relief

This trial tests a wearable sleeve with tiny semiconductor chips to see if it helps relieve period pain (called primary dysmenorrhea). You wear the sleeve during your period, and researchers compare your pain and symptoms before and after using it.

NCT07307222Not yet recruiting
Nerve stimulation for period pain

This trial tests a non-drug treatment using mild electrical pulses to a nerve in the leg (tibial nerve) to reduce pain from primary dysmenorrhea (cramps during your period with no other pelvic condition). It could help if you have painful periods and prefer a drug-free option.

Al Mansurah

Hear when a new Primary Dysmenorrhea trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.